With over 11 million people incarcerated globally, prevention and control of COVID-19 in custodial settings is a critical component of the public health response. Given the risk of rapid transmission in these settings, it is important to know what guidance existed for responding to COVID-19 in the early stages of the pandemic. We sought to identify, collate, and summarise guidance for the prevention and control of COVID-19 in custodial settings in the first six months of 2020.
Many prisoners still struggle to access hospital services despite their significant health care needs and early data suggests the pandemic has worsened access further. In this report, we consider new evidence relating to pre-existing health conditions before prison, the use of remote consultation, different ethnic groups' use of health services and the early impact of the Covid-19 pandemic.
This publication provides an overview of current knowledge and the latest developments in the field of drug use and prison in Europe.
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison — Texas, July–August 2021by WEPHREN
During a COVID-19 outbreak involving the Delta variant in a highly vaccinated incarcerated population, transmission rates were high, even among vaccinated persons.
Simone Thorn Heathcock, Health & Justice Public Health Specialist, PHE London, speaks about responding to a pandemicby Editorial Team
COVID-19 in prisons and other prescribed places of detention (PPDs).